Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Deenova announces successful implementation of Closed Loop Medication Management system at Marienhospital Gelsenkirchen
-
Aerospike Year-over-Year Recurring Revenue Soars by 51% as Demand for AI Rises
-
Qianhai Achieved Tangible Results in Institutional Innovation at the Third Anniversary of the Qianhai Plan
-
Canacol Energy Ltd. Announces the Closing of a US $75 Million Senior Secured Term Loan
-
EpimAb Biotherapeutics and Vignette Bio Announce Strategic Collaboration to Develop EMB-06, a BCMA×CD3 Bispecific Antibody
-
Digital Element Launches New Tools for IP Address Segmentation Mechanisms in Australia - France and Germany on the Horizon
-
PTX Metals Inc. Announces Share Consolidation
-
MediciNova Announces Acceptance of Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial for Presentation at the 2024 Annual NEALS (Northeast Amyotrophic Lateral Sclerosis Consortium) Mee
-
Integrated Power Services Acquires Assets of ABB Industrial Services Business
-
IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances
-
Business First Bancshares, Inc. Receives Regulatory Approval of its Merger with Oakwood Bancshares, Inc.
-
NCL Corporation Ltd. Announces Pricing of $315,000,000 of Senior Notes
-
Cipher Mining Announces August 2024 Operational Update
-
Bird to Host Investor Day October 9, 2024, Introducing 2025-2027 Strategic Plan
-
Brookfield Announces Reset Dividend Rate on Its Series 40 Preference Shares
-
Madison Covered Call and Equity Strategy Fund (MCN) Declares Quarterly Dividend
-
PIMCO Closed-End Funds Declare Monthly Common Share Distributions
-
Algoma Steel Group to Participate in the Jefferies 2024 Industrials Conference
-
Hooker Furnishings Declares Quarterly Dividend
-
Guardian Capital Group Limited completes its acquisition of Galibier Capital Management Ltd.
-
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
-
Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
-
QIAGEN N.V. announces conversion price of new net share settled convertible bonds
-
Change to the Board of Directors of Colabor Group Inc.
-
Diversified Royalty Corp. Announces September 2024 Cash Dividend
-
Petrus Resources Declares Monthly Dividend for September 2024
-
Ascendis Pharma Reports Second Quarter 2024 Financial Results
-
Fairfax Announces Quarterly Dividend on Series C, D, E, F, G, H, I, J, K and M Preferred Shares and Quarterly Dividend Rate for Series D, F, H and J Preferred Shares
-
TransAlta Announces Dividend Rates on Series G Preferred Shares and Series H Preferred Shares
-
Iovance Biotherapeutics to Present at Upcoming Conferences
-
Healthcare Realty Trust Expands Nuveen JV, Bringing Total Year-to-Date Proceeds to Approximately $700 Million
-
Healthcare Realty Trust Expands Nuveen JV, Bringing Total Year-to-Date Proceeds to Approximately $700 Million
-
Element Announces Executive Transition: Celebrating the Leadership of Frank Ruperto and Welcoming Heath Valkenburg as New CFO
-
The New America High Income Fund, Inc. Declares Dividend
-
ARCPOINT PROVIDES CORPORATE UPDATE ON BENEFITS OF CRESSO TRANSACTION
-
Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
-
Protect Pharmaceutical Corp. Announces that KARINCA Logistics Merger Will Not Proceed
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to October 3, 2024
-
Osisko Mining Obtains Interim Order for Plan of Arrangement; Update on Special Meeting for Gold Fields Transaction
-
First Watch Names Rob Conti as Chief Information Officer
-
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Lendmark Financial Services Raises $2.1M for Childhood Cancer Research During its 3-Month ‘Climb to Cure’ Campaign
-
BrightSpring Health Services Announces Definitive Agreement to Acquire Haven Hospice, Expanding Hospice Services into Florida
-
Cellectis Presents Pre-Clinical Evidence of MUC1 CAR T-cells Reducing Triple-Negative Breast Cancer While Preserving Safety
-
Guggenheim Investments Announces September 2024 Closed-End Fund Distributions
-
Zymeworks Reports Inducement Grant Under Nasdaq Stock Market Rule 5635(c)
-
Alumis to Participate in Upcoming September Investor Conferences
-
California Water Service Opens 2024 Firefighter Grant Program
-
Southside Bank Opens Commercial Loan Office in The Woodlands
